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1048Objective: Custodiol (histidine-tryptophan-ketoglutarate solution) is a leading organ preservation solution. On
the basis of this solution, the novel Custodiol-N was developed. The present study investigated the effects of
Custodiol-N in a rat model of heart transplantation.
Methods: Heterotopic heart transplantation was performed in Lewis rats. Four groups were assigned: 2 Custo-
diol-N–treated groups and 2 Custodiol-treated control groups with a reperfusion time of 1 hour and 24 hours,
respectively. Coronary blood flow, left ventricular pressure, its first derivative, left ventricular end-diastolic pres-
sure, endothelium-dependent vasodilatation to bradykinin and endothelium-independent vasodilatation to
sodium nitroprusside, and adenosine triphosphate content were measured. Terminal deoxynucleotidyl transfer-
ase-mediated dUTP-biotin nick end labeling staining was performed to detect apoptotic cardiomyocytes.
Results: After 1 hour, coronary blood flow (3.99  0.24 mL/min/g vs 2.86  0.35 mL/min/g; P< .05), left
ventricular pressure (117 18 mm Hg vs 82 4 mm Hg; P<.05), and first derivative of left ventricular pressure
(3453  577 mm Hg/s vs 1740  116 mm Hg/s; P< .05) were significantly higher in the Custodiol-N group
compared with the corresponding control. The left ventricular systolic pressure–volume relationship was signif-
icantly steeper, indicating improved contractility. Vasodilatatory response to sodium nitroprusside did not show
any major differences between the groups. Response to bradykinin resulted in a significantly higher increase in
coronary blood flow in the Custodiol-N group (92%  4% vs 60%  5%; P< .05). Myocardial adenosine
triphosphate content was significantly higher in the Custodiol-N group (9.84  0.68 mmol/g vs 1.86  0.41
mmol/g; P< .05). Terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end labeling staining
showed a significantly reduced apoptosis level (21.58%  1.59% vs 27.23%  1.54%; P< .05) in the Custo-
diol-N group.
Conclusion: Custodiol-N improves myocardial and endothelial function during the critical phase of reperfusion
after heart transplantation. (J Thorac Cardiovasc Surg 2010;139:1048-56)To date, the major part of routine cardiac surgery is
performed using extracorporal circulation with cardioplegic
arrest. Independently of the technique of cardioplegia,
temporary cardiac dysfunction can be observed frequently
as a consequence of ischemia/reperfusion injury. In addition,
coronary endothelial and peripheral vascular dysfunction
may further complicate the postoperative course. Extracor-
poral circulation is also known to induce a systemic inflam-
matory reaction, with free radical release leading to
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The Journal of Thoracic and Cardiovascular Surrate solution (HTK) (Bretschneider’s solution; Custodiol),
developed by Bretschneider,1 has been established as
a leading cardioprotective solution in the field of routine car-
diac surgery and cardiac transplantation.
In the past 2 decades, it has been shown that not only
ischemia but also reperfusion itself contributes to myocardial
and endothelial injury.2 The pathophysiology of ischemia/
reperfusion injury is complex and involves the production
and release of inflammatory mediators and oxygen free rad-
icals,3 and activation of the coagulation cascade, fibrinolytic
system, and complement chain.4,5 Another mechanism of
cardiac damage after cardiac arrest in heart surgery is in-
duced by hypothermia, which is mainly mediated by an
iron-dependent formation of reactive oxygen species.6,7
The formation of highly reactive species is triggered by
a cold-induced increase in the cellular chelatable iron pool.
A new, iron-independent component of cold-induced injury
was recently described. This iron-independent, chloride-de-
pendent cellular damage was considered a second-line injury,
overshadowed by the iron-dependent component.8
A third mechanism of cardioplegia-induced tissue injury
has its roots in one of the components used in Custodiol: his-
tidine. Histidine has proven to be an excellent buffer and hasgery c April 2010
Abbreviations
ADP ¼ adenosine diphosphate
AMP ¼ adenosine monophosphate
ATP ¼ adenosine triphosphate
dP/dt ¼ first derivative of left ventricular
pressure
dP/dtmax ¼ positive peak of the first derivative of
left ventricular pressure
dP/dtmin ¼ negative peak of the first derivative of
left ventricular pressure
HTK ¼ histidine-tryptophan-ketoglutarate
solution
LV ¼ left ventricle
Pmax ¼ left ventricular systolic pressure
SNP ¼ sodium nitroprusside
TUNEL ¼ terminal deoxynucleotidyl
transferase-mediated dUTP-biotin
nick end labeling
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shown that this protective buffer itself can be the origin of
cytotoxity.9 Like the chloride-dependent cellular damage,
it is overshadowed by the iron-dependent formation of reac-
tive oxygen species.10 But these mechanisms may become
the main limiting factor for cell survival when the strong
iron-dependent component is inhibited.
In a previous screening study, several solutions were
tested in vitro to obtain the composition of Custodiol-N.10
Custodiol-N is a chloride- and histidine-poor cardioplegic
solution based on Custodiol and supplemented by cytopro-
tective amino acids: LK614 and deferoxamine (Table 1).
LK614 is a newly developed, lipophilic, membrane-perme-
able iron chelator quenching intracellular free iron. Deferox-
amine is a well-known extracellular iron chelator. The
present study compares the efficacy and safety of this newly
developed cardioplegic solution with Custodiol in a model
of heterotopic heart transplantation in the rat. The present
study did not investigate the effect of each single component
of the modified solution separately because their modes of
action are well known. We aimed to assess the effects of
the solution as a whole.T
XMATERIALS AND METHODS
Animals and Experimental Groups
Four groups were assigned: 2 Custodiol-N–treated groups and 2 Custo-
diol-treated control groups with reperfusion times of 1 hour and 24 hours,
respectively. Six male Lewis rats weighing 250 to 300 g were used in
each group. Target parameters were assessed after 1 hour of reperfusion
and 24 hours of reperfusion. For the organ bath experiments, a Custodiol-
N group, a Custodiol group, and an additional nonischemic absolute control
group were assigned. In each group, n ¼ 16 aortic rings were assessed. All
animals received humane care in compliance with the ‘‘Principles of Labo-The Journal of Thoracic and Carratory Animal Care,’’ formulated by the National Society for Medical
Research, and the ‘‘Guide for the Care and Use of Laboratory Animals,’’
prepared by the Institute of Laboratory Animal Resources and published
by the National Institutes of Health (Publication No. 86-23, revised
1996). The experiments were approved by the Ethical Committee of the
Land Baden-Wu¨rttemberg for Animal Experimentation.Heterotopic Heart Transplantation
The donor rats were anesthetized with a single intraperitoneal injection
of xylazine (3 mg/kg) and ketamine (100 mg/kg) and heparinized with
400 IU/kg. The abdominal aorta was exposed, and a 1-cm segment of the
infrarenal aorta was occluded by small-vessel forceps. A polytetrafluorethy-
lene catheter (Vygon GmbH & Co. KG, 52017; Aachen, Germany) was
advanced into the aorta. A bilateral thoracotomy was performed, and the
heart was exposed. Cardiac arrest was induced by injection of 40 mL of
Custodiol or Custodiol-N (Dr Franz Ko¨hler Chemie GmbH; Alsbach-Ha¨hn-
lein, Germany). After cardiac arrest, the superior and inferior caval veins
and the pulmonary veins were tied en masse with a 4-0 single silk suture,
and the heart was immediately placed into cold HTK solution (4C).
The recipient rats were anesthetized with a single intraperitoneal injec-
tion of xylazine (3 mg/kg) and ketamine (100 mg/kg) and heparinized
with 400 IU/kg. Two-centimeter segments of the infrarenal aorta and the
caval vein were isolated and occluded by small-vessel forceps. The aorta
and pulmonary artery of the donor heart were anastomosed end to side to
the abdominal aorta and the vena cava, respectively, of the recipient rat.
To minimize variability between experiments, the duration of the implanta-
tion was standardized at 60 minutes. After completion of the anastomoses,
the vessels were released and the heart was then reperfused with blood
in situ.Functional Measurement in the Graft
After 60 minutes, a 3F latex balloon catheter (Edwards Lifesciences
Corp, Irvine, CA) was introduced into the left ventricle (LV) via the apex
and connected to a precision-calibrated syringe for administration and with-
drawal of fluid to determine LV pressure, the first derivative (dP/dt), and
end-diastolic pressure by a Millar micromanometer (Millar Instruments,
Inc, Houston, TX) at different LV volumes. From these data, LV pres-
sure–volume relationships were constructed using PVAN 3.6 software
(Millar Instruments, Inc).
Coronary blood flow was measured by an ultrasonic flow meter mounted
on the donor aorta. Endothelium-dependent vasorelaxation was evaluated
by the peak coronary blood flow after a single bolus injection of bradykinin
(0.2 mL, 104 mol/L) into the left of the graft. Endothelium-independent
vasorelaxation was evaluated equally by a single bolus injection of sodium
nitroprusside (SNP) (0.2 mL, 102 mol/L).In Vitro Organ Bath
The organ bath experiments were performed as previously described.10
Briefly, the descending thoracic aorta was removed and cut transversely
into rings 4 mm wide. Isolated aortic rings of the nonischemic group
were investigated immediately. In the conservation groups, rings were
placed in a test tube containing the different cardioplegic solutions (4C).
The test tubes were closed, and the aortic rings were stored in the respective
cardioplegic solution for 24 hours at 4C. The isolated aortic rings were
mounted on stainless-steel hooks in individual organ baths containing
Krebs–Henseleit solution.10
In Series I, the aortic rings were placed under a resting tension of 2 g.
Phenylephrine (106 mol/L) was used to pre-contract the rings, and relaxa-
tion responses were examined by adding cumulative concentrations of the
endothelium-dependent dilator acetylcholine (109 to 104 mol/L) and endo-
thelium-independent dilator SNP (1010 to 105 mol/L). Because the major
source of free radicals and oxidants produced during ischemia/reperfusiondiovascular Surgery c Volume 139, Number 4 1049
TABLE 1. Compounds of evaluated cardioplegic solutions
Custodiol mmol/L Custodiol-N mmol/L
Naþ 15 16
Kþ 10 10
Mg2þ 4 8
Ca2þ 0.015 0.020
Cl- 50 30
L-histidine 198 124
N-a-acetyl-L-histidine - 57
Tryptophan 2 2
A-ketoglutarate 1 2
Aspartate - 5
Arginine - 3
Alanine - 5
Glycine - 10
Mannitol 30 -
Sucrose - 33
Deferoxamine - 0.025
LK-614 - 0.0075
Composition of the clinically used Custodiol and the newly developed Custodiol-N
solution.
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Xare activated leukocytes in vivo, which are absent in the present in vitro
model, it was necessary to add an external oxidant source to the aortic rings
to better simulate the clinical situation. Thus, in Series II, the aortic rings
were investigated in a similar manner, with additional exposure to hypo-
chlorite (200 mmol/L) for 30 minutes and rinsing before phenylephrine
pre-contraction. Relaxation is expressed as the percentage of contraction
induced by phenylephrine (106 mol/L).
Histologic Analysis
After excision, the hearts were incubated in 4% paraformaldehyde for
histologic staining. The tissues were then fixed in an automatic tissue-fixing
machine and embedded in paraffin. Apoptosis Detection Kit ApopTag Plus
Peroxidase In Situ (Millipore Corporation, 290 Concord Road, Billerica,
MA) was used for staining. Apoptosis detection is based on apoptosis-
induced nuclear DNA fragmentation based on terminal deoxynucleotidyl
transferase-mediated dUTP-biotin nick end labeling (TUNEL). Four watch
fields were randomly selected in each section. Counting the cells was
performed blinded. Positive and total cells were counted using Cell
^
A soft-
ware (Olympus Soft Imaging Solutions GmbH; Mu¨nster, Germany). Cells
were considered apoptotic if more than 10% of the nucleus showed typical
grey-brown color. Apoptosis index (¼positive cells/total cells 3$100%)11
was used as the indicator of apoptosis. To proof the correct procedure of the
staining protocol, a positive control incubated with DNAase prior staining
was provided.
Determination of High-Energy Phosphates
After excision, the hearts were immediately (<1 second) immersed in
fluid nitrogen (196C) and stored frozen at80C until biochemical anal-
ysis. One gram of heart tissue was homogenized in 10 mL of 3.5% HCLO4
and then centrifuged with 20,000 rpm at 5C. Five milliliters of supernatant
were neutralized with 1 mL of triethanolamine-HCL/K2CO3 solution.
Adenosine triphosphate (ATP) degradation was assessed with standard pho-
tometry using enzyme kinetic assay containing glycerinaldehyde-3-phos-
phate dehydrogenase, 3-phosphoglycerate-kinase, glycerin-3-phosphate
dehydrogenase, and triosephosphate-isomerase. ATP, adenosine diphos-
phate (ADP), and adenosine monophosphate (AMP) contents were
expressed as micromoles per gram of dry weight. Energy charge potential
was calculated as (ATPþ0.5ADP)/(ATPþADPþAMP).1050 The Journal of Thoracic and Cardiovascular SurMaterials
All materials used in our study were purchased from Sigma-Aldrich (St
Louis, MO), unless otherwise specified. Custodiol and Custodiol-N (Table
1) were provided by Dr Franz Ko¨hler Chemie GmbH.
Statistical Analysis
All values are expressed as mean  standard error of the mean. Individ-
ual means between the groups were compared by analysis of variance
followed by an unpaired t test with a Bonferroni correction for multiple
comparisons.
RESULTS
Functional Measurement in the Graft
Left ventricular systolic pressure and peak positive dP/dt
were significantly (P<.05) higher in the Custodiol-N group
in comparison with the control group. Systolic cardiac func-
tion curves showed a significant leftward shift in this group
(Figure 1, A, B). Peak negative dP/dt was significantly higher
(P<.05), indicating a better myocardial relaxation (Figure 1,
D). After 24 hours of reperfusion, there were no significant
differences between both groups in the previously
mentioned hemodynamic parameters. Nevertheless, there
was a slight tendency for higher values in left ventricular
systolic pressure and dP/dtmax and dP/dtmin in the Custo-
diol-N group. Left ventricular end-diastolic pressure did
not show any major differences among the 4 groups (Fig-
ure 1, C).
Coronary blood flow measurements showed a significant
(P>.05) increase after 1 hour of reperfusion compared with
the corresponding control. After 24 hours of reperfusion,
coronary blood flow in the Custodiol-N group remained
high but did not show any significant differences. Assess-
ment of endothelium-dependent vasorelaxation as an effect
of bradykinin application showed a significantly increased
vasodilatory response. Meanwhile, endothelium-indepen-
dent vasorelaxation after application of SNP did not show
significant differences (Figure 2).
In Vitro Organ Bath
After 24-hour hypothermic storage in Custodiol, a marked
impairment of endothelial function was demonstrated the in
vitro organ bath experiments. The endothelial dysfunction
was indicated by the reduced maximal relaxation of isolated
aortic rings to acetylcholine and the rightward shift of the
dose-response curve compared with the nonischemic abso-
lute control group.
In the case of long-term storage in the new cardioplegic
solution, enhanced endothelium-dependent vasorelaxation
to acetylcholine was detected when compared with the Cus-
todiol group (Figure 3, A, C). In addition, pD2 ¼logEC50
(M) (EC50 ¼ half maximal response) to acetylcholine
showed significant improvements in the Custodiol-N group
in both series without NaOCl incubation (7.33  0.07# vs
7.03  0.09*# vs 6.69  0.07*; control vs Custodiol-N vs
Custodiol; *P< .05 vs control; #P< .05 vs Custodiol) andgery c April 2010
FIGURE 1. Hemodynamic analysis. A, Left ventricular peak systolic pressure – left ventricular volume. B, Maximum pressure development (dP/dtmax) –
left ventricular volume. C, Left ventricular end-diastolic pressure – left ventricular volume. D, Minimum pressure development (dP/dtmin) at an intraventric-
ular volume of 80 mL after 1 hour of reperfusion. All values are given as mean  standard error of the mean (SEM). *P< .05 vs other groups. LVSP, Left
ventricular peak systolic pressure; LVV, left ventricular volume; LVEDP, left ventricular end-diastolic pressure.
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Xwith NaOCl incubation (7.33 0.07 vs 6.88 0.16* vs 6.75
 0.09*; control vs Custodiol-N vs Custodiol; *P< .05 vs
control). As expected, endothelial function showed a stron-
ger impairment after NaOCl incubation. In regard to the
endothelium-independent vascular smooth muscle function
of the aortic rings, which was indicated by endothelium-
independent vasorelaxation with SNP (Figure 3, B, D), thereThe Journal of Thoracic and Carwere no significant differences among the groups. Neverthe-
less, pD2 to SNP showed enhancements in the Custodiol-N
group (8.27 0.04* vs 8.55 0.07 vs 8.17 0.04*; control
vs Custodiol-N vs Custodiol; *P< .05 vs Custodiol-N).
After NaOCl incubation, no significant differences remained
among the groups (8.27  0.04 vs 8.43  0.09 vs 8.25
 0.06; control vs Custodiol-N vs Custodiol).diovascular Surgery c Volume 139, Number 4 1051
FIGURE 2. Coronary blood flow. Baseline coronary blood flow (A) and vasodilator response after application of the endothelium-dependent vasodilator
bradykinin (0.1 nmol, 0.2 mL, B) and the endothelium-independent vasodilator SNP (10 nmol, 0.2 mL, C). All values are given as mean  SEM. *P<
.05 vs corresponding control. CBF, Coronary blood flow; BRK, bradykinin; SNP, sodium nitroprusside.
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Figure 4 shows representative TUNEL staining in the
control and Custodiol-N groups after 1 hour and 24 hours
of reperfusion. Few apoptotic cells were found in the Custo-
diol-N group. In contrast, control group samples showed
many TUNEL-positive nuclei. These results were confirmed
by semiquantitative analysis of the apoptosis index. Figure 4,
E shows that the apoptosis index in control group rats was
significantly higher than in the Custodiol-N group after 1
hour of reperfusion. After 24 hours of reperfusion, the
apoptosis indices of both groups increased. Nevertheless,
there were still significantly fewer apoptotic cells in the
Custodiol-N group than in the control group.Biochemical Analysis
Myocardial high-energy phosphate contents, especially
ATP content, were preserved with Custodiol-N during heart
transplantation (Table 2). ADP levels did not significantly
differ among the different groups. Nevertheless, there was
a strong tendency for higher ADP levels in the Custodiol-
N group. Concomitantly, AMP levels were significantly
lower in this group compared with the corresponding control
group. Energy charge potential as an indicator of the myo-
cardial energy level showed a significant improvement
with the novel Custodiol-N solution.DISCUSSION
Presently, the major part of cardiac surgery relies on
cardiac arrest induced by different cardioplegic solutions.
Bretschneider’s solution (Custodiol) was developed for
organ conservation, but it is also widely used as a cardiople-
gic solution in routine cardiac surgery. Despite the capability1052 The Journal of Thoracic and Cardiovascular Surof Bretschneider’s solution (Custodiol) to effectively reduce
energy requirements,12 it has been shown that damages
occurring during reperfusion are left unaddressed by this
cardioplegic solution and other solutions. Several pathways
of oxidative stress have been implicated in the pathophysiol-
ogy of severe damage after reperfusion. The fundamental
pathway of cardiac damage during this phase is the produc-
tion of superoxide anion, hydrogen peroxide, and possibly
singlet oxygen.13 In support of the previously mentioned
agents, reactive oxygen species formed in an iron-dependent
manner have been discovered to play a crucial role in cold-
induced injury.14 Recent studies10 clearly confirm the inabil-
ity of the HTK solution (Custodiol) to reduce reperfusion in-
jury after long-term cold ischemic storage. Custodiol-N
addresses this issue using LK-614 and the well-known de-
feroxamine as iron chelators quenching free iron (Table 1).
LK614 [1-(N-hydroxy-N-methylcarbamide)-3,4-dime-
thoxybenzol] is a newly developed iron chelator. The
aromatic ring of LK614 concedes enough lipophilicity to
allow membrane permeability.15 Because of the combina-
tion of LK614 and deferoxamine, Custodiol-N reduces the
load of free intracellular and extracellular Fe3þ, leading to
a strong reduction of hydroxyl radicals and iron-dependent
reactive oxygen species, again leading to improved myocar-
dial protection because of the reduction of oxidative stress.10
The amino acid histidine is an excellent buffer and there-
fore used as a ‘‘physiologic’’ buffer in the HTK solution.
However, it was recently reported that histidine contributes
decisively to preservation solution toxicity. The mechanism
behind this toxicity has not been completely solved, but it
has been proved that this mechanism is linked to an
increased production of iron-dependent reactive oxygen
species, most likely by histidine entering the cells andgery c April 2010
FIGURE 3. Vascular function after 24-hour cold storage. Concentration-response curves of acetylcholine. A, Acetylcholine-induced endothelium-
dependent vasorelaxation in aortic rings after 24-hour cold ischemic storage. B, SNP-induced endothelium-independent vasorelaxation in aortic rings after
24-hour cold ischemic storage. C, Acetylcholine-induced endothelium-dependent vasorelaxation in aortic rings after 24-hour cold ischemic storage and
additional NaOCl preincubation. D, SNP-induced endothelium-independent vasorelaxation in aortic rings after 24-hour cold ischemic storage and additional
NaOCl preincubation. Each point on the curves and each column represent the mean SEM of 16 experiments in thoracic aortic rings of the different groups.
*P< .05 vs absolute control.
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Xforming redox-active complexes with cellular chelatable
iron and thereby forming reactive oxygen species.9 Apart
from its toxicity, histidine has proven to be an excellent
buffer. N-a-acetyl-L-histidine, a naturally occurring16
N-substituted derivate of histidine, is an attractive buffer to
replace histidine. It shares the benefits of histidine and has
almost no toxicity.9 The reason for this is most likely the
decreased cellular uptake of N-a-acetyl-L-histidine and its
altered affinity for iron. This issue was addressed by partially
replacing histidine by N-a-acetyl-L-histidine in Custodiol-N
(Table 1).
Iron-independent cellular damage dependent on extracel-
lular chloride concentrations was recently described.8 How-
ever, the underlying molecular mechanisms remain unclear.
Nevertheless, it has been hypothesized that the Cl-/HCO3
-
exchanger most likely is involved in the mechanism of apo-
ptosis. The Cl- efflux from cells or HCO3
- influx to cellsThe Journal of Thoracic and Car(consequently increasing the pH level) may play an impor-
tant role in signal transduction leading to events such as ac-
tivation of caspase, which again is an important inductor of
apoptosis.17 This mechanism was taken into consideration,
and the Cl--concentration in Custodiol-N was reduced and
partially replaced by aspartate (Table 1). Thus, increasing
pH levels and the activation of caspase (in a final step)
were reduced, also leading to a reduction of apoptosis in
myocardial tissue and conservation of myocardial function
after cold storage.
Another point that has been taken into account in the
development of Custodiol-N is the protective effects of
some amino acids, such as glycine, alanine, and arginine.
The mechanism of action of glycine in cytoprotection of
cells exposed to hypoxia or cold ischemia has been sug-
gested to be based on the stabilizing effect of the plasma
membrane. Glycine suppresses the release of intracellulardiovascular Surgery c Volume 139, Number 4 1053
FIGURE 4. Histologic analysis. TUNEL staining after 1 hour and 24 hours of reperfusion; Control group also shows high apoptosis rate (grey-brown–col-
ored nuclei) after 1 hour (A) and 24 hours (C). Custodiol-N group rarely shows any apoptotic cells after 1 hour (B) and 24 hours (D); apoptosis index (E).
Control after 1-hour reperfusion versus Custodiol-N after 1-hour reperfusion and control after 24-hour reperfusion versus Custodiol-N after 24-hour reper-
fusion. Values are given as mean  SEM. *P< .05 vs corresponding control; 2003 magnification. CN, Control.
TABLE 2. Biochemical analysis
Control
1-h
reperfusion
Custodiol-N
1-h reperfusion
Control
24-h reperfusion
Custodiol-N
24-h reperfusion
ATP 1.86  0.41 9.84  0.68* 2.65  0.49 8.05  1.62*
ADP 2.05  0.42 3.07  0.30 3.35  0.55 3.28  0.41
AMP 2.07  0.22 0.91  0.13* 0.49  0.14 0.83  0.14*
ECP 0.49  0.04 0.82  0.01* 0.53  0.05 0.79  0.01*
ATP, Adenosine triphosphate; ADP, adenosine diphosphate; AMP, adenosine mono-
phosphate; ECP, energy charge potential. All values are given as mean  SEM.
*P< .05 vs corresponding control.
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Xenzymes of damaged cells. It has been suggested that this
membrane-stabilizing effect of glycine is mediated by
specific membrane-bound receptors.18 However, the protec-
tive pathway still remains unclear and requires further inves-
tigation to be understood sufficiently. Although the
mechanism of cytoprotection is still unclear for glycine,
this amino acid has proven its beneficial effects on ische-
mia/reperfusion injury and has therefore been introduced
into Custodiol-N.
Alanine was supplemented in Custodiol-N because this
amino acid is known to inhibit the hypoxia-associated
sodium influx into the myocytes. During ischemia, the for-
mation of unspecific membrane pores leads to intracellular
sodium accumulation followed by chloride influx, cell
swelling, and consequent cellular damage.19 By adding
this amino acid, this negative course of cell swelling and
apoptosis was decelerated.
Arginine is the precursor of nitric oxide. The beneficial
effects of nitric oxide, such as increasing the postischemic
blood flow, decreasing leukocyte adhesion, and expressing
cell adhesion molecules, have been well explored. The
administration of arginine improves the production of nitric
oxide, especially in conditions with endothelial injury with
subsequent diminished basal endothelial nitric oxide
production (eg, in ischemia/reperfusion).20
In addition to these specific protective effects of the
previously mentioned amino acids, all amino acids have
buffering capabilities, which are important in organ preser-1054 The Journal of Thoracic and Cardiovascular Survation solutions. These additional buffering capabilities
advance the specific protective effects of each amino acid.21
The focus of this study was the protection of the myocar-
dial tissue against the hypothermic damage during cardio-
plegic arrest associated with Bretschneider’s solution
(Custodiol). Therefore, this solution was modified in 4 cru-
cial ways: 1) addition of deferoxamine and LK614 as iron
chelators to reduce the iron-dependent production of reac-
tive oxygen species, 2) substitution of histidine by N-a-ace-
tyl-l-histidine to inhibit the histidine-associated forming of
redox active complexes, 3) reduction of the chloride concen-
tration to diminish Cl--activated induction of apoptosis, and
4) addition of cytoprotective amino acids.18–21
In support of our results, these mechanisms show im-
proved myocardial protection after cardioplegic arrest andgery c April 2010
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Xrecovery of myocardial function; the more rapid recovery of
the hemodynamic parameters in comparison with Bretsch-
neider’s solution (Custodiol) especially shows the effective-
ness of these modifications (Figure 1). After 24 hours, we
were not able to record any further improvement using
Custodiol-N. These data lead to the hypothesis that the
Custodiol-N group reaches almost full functional recovery
after 1 hour of reperfusion. This hypothesis is also supported
by the data of one of our previous studies in which we per-
formed a nonischemic heart transplantation using a slightly
modified operation technique.22 This group showed similar
hemodynamic results as the Custodiol-N group after 1 hour
of reperfusion.
However, our biochemical data (Table 2) also indicate an
improved myocardial energy state during early and late
reperfusion. Nevertheless, the advancements of Custodiol-
N seem to be more apparent during early reperfusion. The
slight reduction in high-energy phosphate content after 24
hours in comparison with 1 hour in the Custodiol-N group
(Table 2) may be explained by myocardial unloading and
a consequent adaption of the myocardium to these changed
conditions.
This idea of myocardial protection during early and late
reperfusion is also supported by the results of our histologic
analysis (Figure 4, A–D). TUNEL staining is sensitive to
double-strand breaks in the DNA of the nucleus; subse-
quently, this method is sensitive to the damage caused by
reactive oxygen species inducing such damage and thereby
also inducing apoptosis in a final step. The histologic analy-
sis revealed that Custodiol-N powerfully reduced this type of
damage and apoptosis (Figure 4, E).
In addition to our previous results, coronary blood flow
measurement and in vitro organ bath experiments show
that not only myocardial tissue but also endothelium
benefited from these additional protection mechanisms
(Figure 2). This is in accordance with a recent report of
our research group showing the beneficial effects of iron
chelators in cold storage-induced damage on endothelial
dysfunction.10 The preservation of endothelial function
and thereby an increased coronary blood flow may be partly
responsible for the fast myocardial recovery and the
improved myocardial energy state in our study.
CONCLUSIONS
These modifications of Custodiol can effectively reduce
myocardial and endothelial damage after ischemia/reperfu-
sion; however, functional improvements mainly occur
during the early reperfusion phase. The phase of late reper-
fusion did not show any major differences in the functional
parameters. The reduction of cardiac impairment, especially
during the critical phase of early reperfusion, is known to
improve the postoperative outcome.23 The mechanisms
addressed by our modifications have been reported and
described by other research groups, as well by our ownThe Journal of Thoracic and Cargroup.6,8-10,14,17,24 Nevertheless, these findings have not
been implemented in a cardioplegic solution. Custodiol-N
is a novel cardioplegic solution showing how effectively
a ‘‘cocktail’’ of many minor modifications, which have
been analyzed extensively one by one,6,8-10,14,17,24 can
protect myocardial tissue during ischemia/reperfusion. Our
data indicate that Custodiol-N may have beneficial effects
in patients undergoing surgical interventions on the heart
with cardioplegic arrest.References
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